Domingo Liotta Hospital, Houston, Texas. First Clinical use. 1966 (August 8): Liotta-DeBakey LVAD in a paracorporeal position in cardiogenic shock postcardiotomy, Methodist Hospital, Houston, Texas. First successful clinical use. 1969 (April 4): Liotta-Cooley Total Artificial Heart, Texas Heart Institute, Houston, Texas. First clinical use. http://www.texasheartinstitute.org/Research/Devices/liotta.cfm. This device was stolen from the lab of Dr. Michael E. DeBakey by Liotta. Dr. Cooley was not involved in any way in its development. The device had not been successful in animal experiments, and while the patient had the artificial heart in place he developed multiple system organ failure, as the experimental animals had, and died
Artificial bone fractured bone. However, if damage to bone is caused by a disease or severe injury, it becomes difficult for the body to repair itself. When the human body is unable to regenerate the lost bone tissue, surgeons come in and replace the missing bone using autografts, allografts, and synthetic grafts (artificial bone). When compare artificial bone to autograft and allograft, it is less invasive and more biocompatible since it avoids the risk of unknown viral infections. When designing implanted biomaterials, key criteria are biocompatibility, osteoconductivity, high porosity and biomechanics compatibility. Artificial bone was initially made of materials like metals and